Guangdong Yili Luoding Pharmaceutical

Guangdong Yili Luoding Pharmaceutical, now officially known as Yili Pharmaceutical (Luoding) Co., Ltd., is a prominent Chinese pharmaceutical manufacturer and a key subsidiary of Yili Pharmaceutical Co., Ltd. Based in Luoding, Guangdong, the company operates a large-scale, GMP-certified production facility specializing in Traditional Chinese Medicine (TCM) and chemical generic drugs. Its core portfolio includes treatments for gout, such as the innovative TCM Tiger-Chasteberry Qingfeng Capsules and Febuxostat tablets, as well as gastrointestinal medications like Omeprazole. The company also produces a wide range of pediatric and respiratory products, including Xiao'er Xiangru Granules. With a focus on green manufacturing and modernizing TCM, the company integrates R&D, production, and sales to serve the domestic Chinese healthcare market.